financetom
Business
financetom
/
Business
/
Two plead guilty to insider trading in Kodak before Trump loan announcement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Two plead guilty to insider trading in Kodak before Trump loan announcement
Apr 3, 2024 11:51 AM

NEW YORK (Reuters) - A former pharmaceutical executive and his cousin pleaded guilty on Wednesday to insider trading in Eastman Kodak ( KODK ), based on tips that the company was arranging a surprise $765 million loan from the Trump administration to make drug ingredients.

Andrew Stiles and Gray Stiles each admitted to one count of securities fraud at a hearing before U.S. District Judge Ronnie Abrams in Manhattan.

Both defendants were accused of buying Kodak shares in anticipation of the U.S. International Development Finance Corp loan to the former photography giant, and selling them after the loan was announced on July 28, 2020.

Prosecutors said this led to more than $500,000 of illegal profit for Andrew Stiles and more than $700,000 for Gray Stiles.

Lawyers for the defendants did not immediately respond to requests for comment.

Andrew Stiles was a vice president at Phlow, a Richmond, Virginia-based medicine supply chain company working with Kodak, when he allegedly learned about the loan and tipped his cousin.

An indictment included coded text messages between the pair, including where Gray Stiles referred to the loan as "film we sent off a few weeks ago to get developed."

Sentencing is scheduled for July 24.

Andrew Stiles, of Charleston, South Carolina, could face 21 to 27 months in prison under his plea agreement. Gray Stiles, of Richmond, could face 10 to 16 months. Fines are also possible.

Shares of Rochester, New York-based Kodak soared to $60 from $2.62 within two days of the loan's announcement, as the company sought to remake itself.

At a press briefing, Trump called Kodak a "great American company" with "one of the great brands in the world," and said the loan would give it the capacity to produce up to 25% of the active ingredients needed to produce generic drugs domestically.

"We must never be reliant on a foreign nation for America's medical or other needs," Trump said.

The loan was never issued.

Both defendants also faced related civil charges by the U.S. Securities and Exchange Commission. That case has been on hold pending a resolution of the criminal case.

Kodak and Phlow were not charged.

The case is U.S. v. Stiles et al, U.S. District Court, Southern District of New York, No. 23-cr-00098.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved